Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex

Neurobiology of Disease

Volumn 37, Issue 3, 2010, Pages 764-771

  Zeng, Ling Hui ^a   Bero, Adam W ^a   Zhang, Bo ^a   Holtzman, David M ^a   Wong, Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ceftriaxone; Epilepsy; Epileptogenesis; Glia; GLT 1; Mice; Seizure

Indexed keywords

CEFTRIAXONE; GLUTAMATE TRANSPORTER; PROTEIN S6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; EPILEPSY; EPILEPTOGENESIS; FEMALE; MALE; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SURVIVAL RATE; TUBEROUS SCLEROSIS; WEIGHT GAIN;

ANIMALS; ASTROCYTES; CEFTRIAXONE; CELL DEATH; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EPILEPSY; EXCITATORY AMINO ACID TRANSPORTER 2; EXTRACELLULAR FLUID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; MICE; MICE, KNOCKOUT; SURVIVAL RATE; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 75949105125     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.12.020     Document Type: Article

References (42)

1. Akbar M.T., Rattray M., Williams R.J., Chong N.W., and Meldrum B.S. Reduction of GABA and glutamate transporter messenger RNAs in the severe-seizure genetically epilepsy-prone rat. Neuroscience 85 (1998) 1235-1251
2. Bajenaru M.L., Zhu Y., Hedrick N.M., Donahoe J., Parada L.F., and Gutmann D.H. Astrocyte-specific inactivation of the neurofibromatosis (NF1) gene is insufficient for astrocytoma formation. Mol. Cell. Biol. 22 (2002) 5100-5113
3. Chu K., Lee S.T., Sinn D.I., Ko S.Y., Kim E.H., Kim J.M., Kim S.J., Park D.K., Jung K.H., Song E.C., Lee S.K., Kim M., and Roh J.K. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 38 (2007) 177-182
4. Cirrito J.R., May P.C., O'Dell M.A., Taylor J.W., Parsadanian M., Cramer J.W., Audia J.E., Nissen J.S., Bales K.R., Paul S.M., DeMattos R.B., and Holtzman D.M. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life. J. Neurosci. 23 (2003) 8844-8853
5. Crino P.B., Shumate M.D., Robinson M.B., Coulter D.A., and Brooks-Kayal A.R. Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilepsia 43 (2002) 211-218
6. Crino P.B., Nathanson K.L., and Henske E.P. The tuberous sclerosis complex. N. Engl. J. Med. 355 (2006) 1345-1356
7. Dutuit M., Touret M., Szymocha R., Nehlig A., Belin M.F., and Didier-Bazes M. Decreased expression of glutamate transporters in genetic absence epilepsy rats before seizure occurrence. J. Neurochem. 80 (2002) 1029-1038
8. Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., Ramesh V., and Silva A.J. Reversal of learning deficits in a Tsc2(+/-) mouse model of tuberous sclerosis. Nat. Med. 14 (2008) 843-848
9. Erbayat-Altay E., Zeng L.H., Xu L., Gutmann D., and Wong M. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis. Epilepsia 48 (2007) 1470-1476
10. Ganel R., Ho T., Maragakis N.J., Jackson M., Steiner J.P., and Rothstein J.D. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol. Dis. 21 (2006) 556-567
11. Harrington E.P., Moddel G., Najm I.M., and Baraban S.C. Altered glutamate receptor-transporter expression and spontaneous seizures in rats exposed to methylaxoxymethanol in utero. Epilepsia 48 (2007) 158-168
12. Holmes G.L., Stafstrom C.E., and the Tuberous Sclerosis Study Group. Tuberous Sclerosis Complex and epilepsy: recent developments and future challenges. Epilepsia 48 (2007) 617-630
13. Howland D.S., Liu J., She Y., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1604-1609
14. Ingram E.M., Wiseman J.W., Tessler S., and Emson P.C. Reduction of glial glutamate transporters in the parietal cortex and hippocampus of the EL mouse. J. Neurochem. 79 (2001) 564-575
15. Jelenkovic A.V., Jovanovic M.D., Stanimirovic D.D., Bokonjic D.D., Ocic G.G., and Boskovic B.S. Beneficial effects of ceftriaxone against pentylenetetrazole-evoked convulsions. Exp. Biol. Med. 233 (2008) 1389-1394
16. Kwiatkowski D.J. Tuberous sclerosis: from tubers to mTOR. Ann. Hum. Genet. 67 (2003) 87-96
17. Lee S.G., Su Z.Z., Emdad L., Gupta P., Sarakar D., Borajabad A., Volsky D.J., and Fisher P.B. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem. 283 (2008) 13116-13123
18. Lepore A.C., Rauck B., Dejea C., Pardo A.C., Rao M.S., Rothstein J.D., and Maragakis N.J. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 11 (2008) 1294-1301
19. Lipski J., Wan C.K., Bai J.Z., Pi R., Li D., and Donnelly D. Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146 (2007) 617-629
20. Mathern G.W., Mendoz D., Lozada B.S., Pretorius J.K., Dehnes Y., Danbolt N.C., Nelson N., Leite J.P., Chimelli L., Born D.E., Sakamoto A.C., Assirati J.A., Fried I., Peacock W.J., Ojemann G.A., and Adelson P.D. Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52 (1999) 453-472
21. Meikle L., Pollizzi K., Egnor A., Kramvis I., Lane H., Sahin M., and Kwiatkowski D.J. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J. Neurosci. 28 (2008) 5422-5432
22. Menacherry S., Hubert W., and Justice J.B. In vivo calibration of microdialysis probes for exogenous compounds. Anal. Chem. 64 (1992) 577-583
23. Milh M., Becq H., Villeneuve N., Ben-Ari Y., and Aniksztejn L. Inhibition of glutamate transporters results in a "suppression-burst" pattern and partial seizures in the newborn rat. Epilepsia 48 (2007) 169-174
24. Miller H.P., Levey A.I., Rothstein J.D., Tzingounis A.V., and Conn P.J. Alterations in glutamate transporter protein levels in kindling-induced epilepsy. J. Neurochem. 68 (1997) 1564-1570
25. Miller B.R., Dorner J.L., Shou M., Sari Y., Barton S.J., Sengelaub D.R., Kennedy R.T., and Rebec G.V. Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience 153 (2008) 329-337
26. Proper E.A., Hoogland G., Kappen S.M., Jansen G.H., Rense G.A., Schrama L.H., van Veelen C.W.M., van Rijen P.C., van Nieuwenhuizen O., Gispen W.H., and de Graan P.N.E. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125 (2002) 32-43
27. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
28. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Hoberg M.D., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., and Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 43 (2005) 73-77
29. Samuelsson C., Kumlien E., Flink R., Lindholm D., and Ronne-Engström E. Decreased cortical levels of astrocytic glutamate transport protein GLT-1 in a rat model of posttraumatic epilepsy. Neurosci. Lett. 289 (2000) 185-188
30. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
31. Sosunov A.A., Wu X., Weiner H.L., Mikell C.B., Goodman R.R., Crino P.D., and McKhann II G.M. Tuberous sclerosis: a primary pathology of astrocytes?. Epilepsia 49 Suppl. 2 (2008) 53-62
32. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., and Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276 (1997) 1699-1702
33. Tang S.J., Reis G., Kang H., Gingras A.C., Sonenberg N., and Schuman E.M. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 467-472
34. Tessler S., Danbolt N.C., Faull R.L.M., Storm-Mathisen J., and Emson P.C. Expression of the glutamate transporters in human temporal lobe epilepsy. Neurosci 88 (1999) 1083-1091
35. Thone-Reineke C., Neumann C., Namsolleck P., Schmerbach K., Krikov M., Schefe J.H., Lucht K., Hortnagl H., Godes M., Muller S., Rumschussel K., Funke-Kaiser H., Villringer A., Steckelings U.M., and Unger T. The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induce neurotrophins in stroke. J. Hypertens. 26 (2008) 2426-2435
36. Uhlmann E.J., Wong M., Baldwin R.L., Bajenaru M.L., Onda H., Kwiatkowski D.J., Yamada K.A., and Gutmann D.H. Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann. Neurol. 52 (2002) 285-296
37. Watanabe T., Morimoto K., Hirao T., Suwaki H., Watase K., and Tanaka K. Amygdala-kindled and pentyleneterazole-induced seizures in glutamate transporter GLAST-deficient mice. Brain Res. 36 845 (1999) 92-96
38. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 49 (2008) 8-21
39. Wong M., Ess K.E., Uhlmann E.J., Jansen L.A., Li W., Crino P.B., Mennerick S., Yamada K.A., and Gutmann D.H. Impaired astrocyte glutamate transport in a mouse epilepsy model of tuberous sclerosis complex. Ann. Neurol. 54 (2003) 251-256
40. Wu X., Sosunov A.A., Tikoo R., Weiner H.L., Crino P.B., and McKhann II G.M. Glutamate transport is impaired in the human tuberous sclerosis tissue. Epilepsia 46 S8 (2005) 279
41. Zeng L.H., Ouyang Y., Gazit V., Cirrito J.R., Jansen L.A., Ess K.C., Yamada K.A., Wozniak D.F., Holtzman D.M., Gutmann D.H., and Wong M. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol. Dis. 28 (2007) 184-196
42. Zeng L.H., Xu L., Gutmann D.H., and Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann. Neurol. 63 (2008) 444-453